Wednesday, September 26th, 2018 |
0 Comments
In this issue we look at what you need to know about coeliac disease and gluten intolerance. There’s news (from p.4) about Dexcom buying TypeZero (a diabetes management platform), Novo Nordisk buying Ziylo (developer of glucose binding molecules, leading to the development
read more »